The association between atorvastatin use and prothrombin time, apolipoprotein A-I levels, and apolipoprotein B levels in patients with type 2 diabetes mellitus and no history of atherosclerotic cardiovascular diseases: a cross-sectional study

Taima’a Kefah Al-Mohammad, Linda Tahaineh, Shoroq M. Altawalbeh

Open source

DOI
10.6084/m9.figshare.33606262.v1
Published
2026
Container
Not recorded
Publisher
Taylor & Francis
Open access
yes

Credibility signals

limited evidence Score 47/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.6084/m9.figshare.33606262.v1,
  title = {The association between atorvastatin use and prothrombin time, apolipoprotein A-I levels, and apolipoprotein B levels in patients with type 2 diabetes mellitus and no history of atherosclerotic cardiovascular diseases: a cross-sectional study},
  author = {Taima’a Kefah Al-Mohammad and Linda Tahaineh and Shoroq M. Altawalbeh},
  year = {2026},
  doi = {10.6084/m9.figshare.33606262.v1},
  url = {https://doi.org/10.6084/m9.figshare.33606262.v1}
}

RIS

TY  - JOUR
TI  - The association between atorvastatin use and prothrombin time, apolipoprotein A-I levels, and apolipoprotein B levels in patients with type 2 diabetes mellitus and no history of atherosclerotic cardiovascular diseases: a cross-sectional study
AU  - Taima’a Kefah Al-Mohammad
AU  - Linda Tahaineh
AU  - Shoroq M. Altawalbeh
PY  - 2026
DO  - 10.6084/m9.figshare.33606262.v1
UR  - https://doi.org/10.6084/m9.figshare.33606262.v1
ER  - 

APA

Al-Mohammad, T. K., Tahaineh, L., & Altawalbeh, S. M. (2026). The association between atorvastatin use and prothrombin time, apolipoprotein A-I levels, and apolipoprotein B levels in patients with type 2 diabetes mellitus and no history of atherosclerotic cardiovascular diseases: a cross-sectional study. https://doi.org/10.6084/m9.figshare.33606262.v1

Source records